Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Arrhythmias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 179 articles:
HTML format
Text format



Single Articles


    August 2019

  1. Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideli
    Circulation. 2019;140:e285.
    PubMed     Text format    


    June 2019
  2. ALSINA KM, Hulsurkar M, Brandenburg S, Kownatzki-Danger D, et al
    Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation.
    Circulation. 2019 Jun 12. doi: 10.1161/CIRCULATIONAHA.119.039642.
    PubMed     Text format     Abstract available


  3. SAHASHI Y, Naruse G, Okura H
    Three Different Types of Tachyarrhythmia and QT Prolongation in a Suicide Attempt.
    Circulation. 2019;139:2703-2706.
    PubMed     Text format    


  4. WAHBI K, Ben Yaou R, Gandjbakhch E, Anselme F, et al
    Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.
    Circulation. 2019 Jun 3. doi: 10.1161/CIRCULATIONAHA.118.039410.
    PubMed     Text format     Abstract available


    May 2019
  5. LIP GYH, Khan AA, Olshansky B
    Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation.
    Circulation. 2019;139:2301-2303.
    PubMed     Text format    


  6. STAM-SLOB MC, Connolly SJ, van der Graaf Y, van der Leeuw J, et al
    Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation: Results from the RE-LY Trial.
    Circulation. 2019 May 3. doi: 10.1161/CIRCULATIONAHA.118.035266.
    PubMed     Text format     Abstract available


    April 2019

  7. Correction to: Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
    Circulation. 2019;139:e889.
    PubMed     Text format    


  8. KHERA R, Tang Y, Girotra S, Nadkarni VM, et al
    Pulselessness After Initiation of Cardiopulmonary Resuscitation for Bradycardia in Hospitalized Children: Prevalence, Predictors of Survival, and Implications for Hospital Profiling.
    Circulation. 2019 Apr 22. doi: 10.1161/CIRCULATIONAHA.118.039048.
    PubMed     Text format     Abstract available


  9. WANG TY
    Effectively Initiating and Maintaining Anticoagulation in Patients With Atrial Fibrillation.
    Circulation. 2019;139:1763-1765.
    PubMed     Text format    


  10. KOMATSU Y, Hocini M, Nogami A, Maury P, et al
    Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction: A Multicenter Study.
    Circulation. 2019 Apr 1. doi: 10.1161/CIRCULATIONAHA.118.037997.
    PubMed     Text format     Abstract available


    March 2019
  11. LEI M, Wu L, Terrar DA, Huang CL, et al
    Response by Lei et al to Letter Regarding Article, "Modernized Classification of Cardiac Antiarrhythmic Drugs".
    Circulation. 2019;139:1652-1653.
    PubMed     Text format    


  12. HU D, Huang Y, Huang C
    Letter by Hu et al Regarding Article, "Modernized Classification of Cardiac Antiarrhythmic Drugs".
    Circulation. 2019;139:1650-1651.
    PubMed     Text format    



  13. Correction to: Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Circulation. 2019;139:e635.
    PubMed     Text format    


  14. CHEEN MHH
    Letter by Cheen Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States".
    Circulation. 2019;139:1561-1562.
    PubMed     Text format    


  15. SIONTIS KC, Zhang X, Schaubel DE, Yao X, et al
    Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States".
    Circulation. 2019;139:1563-1564.
    PubMed     Text format    


  16. JUKEMA JW, Timal RJ, Rotmans JI, Hensen LCR, et al
    Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients: The Prospective Randomized Controlled ICD2 Trial.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039818.
    PubMed     Text format     Abstract available


  17. MULDER BA, van Gelder IC, Rienstra M
    Device-Detected Atrial Fibrillation: Evidencing the Knowledge Gap.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040549.
    PubMed     Text format     Abstract available


  18. PERINO AC, Fan J, Askari M, Heidenreich PA, et al
    Practice Variation in Anticoagulation Prescription and Outcomes after Device-Detected Atrial Fibrillation: Insights from the Veterans Health Administration.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.118.038988.
    PubMed     Text format     Abstract available


    February 2019
  19. HOHNLOSER SH, Fudim M, Alexander JH, Wojdyla DM, et al
    Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Extremes in Body Weight: Insights from the ARISTOTLE Trial.
    Circulation. 2019 Feb 18. doi: 10.1161/CIRCULATIONAHA.118.037955.
    PubMed     Text format     Abstract available


  20. YAMADA N, Asano Y, Fujita M, Yamazaki S, et al
    Mutant KCNJ3 and KCNJ5 Potassium Channels as Novel Molecular Targets in Bradyarrhythmias and Atrial Fibrillation.
    Circulation. 2019 Feb 15. doi: 10.1161/CIRCULATIONAHA.118.036761.
    PubMed     Text format     Abstract available


  21. HYLEK EM
    Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation.
    Circulation. 2019;139:772-774.
    PubMed     Text format    


  22. LINK MS
    Important Changes for Practicing Physicians in the Focused Atrial Fibrillation Guideline Update.
    Circulation. 2019 Feb 1. doi: 10.1161/CIRCULATIONAHA.118.038300.
    PubMed     Text format    


  23. UPADHYAY GA, Cherian T, Shatz DY, Beaser AD, et al
    Intracardiac Delineation of Septal Conduction in Left Bundle Branch Block Patterns: Mechanistic Evidence of Left Intra-Hisian Block Circumvented by His Pacing.
    Circulation. 2019 Feb 1. doi: 10.1161/CIRCULATIONAHA.118.038648.
    PubMed     Text format     Abstract available


    January 2019
  24. PICCINI JP, Xu H, Cox M, Matsouaka RA, et al
    Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).
    Circulation. 2019 Jan 31. doi: 10.1161/CIRCULATIONAHA.118.035909.
    PubMed     Text format     Abstract available


  25. JANUARY CT, Wann LS, Calkins H, Chen LY, et al
    2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation.
    Circulation. 2019 Jan 28:CIR0000000000000665. doi: 10.1161/CIR.0000000000000665.
    PubMed     Text format    


  26. ZHANG S, Cuculich PS, Noheria A
    Atrial Flutter With Narrow QRS Complexes in a Patient With Pacemaker.
    Circulation. 2019;139:407-409.
    PubMed     Text format    


  27. CHAO TF, Lip GYH, Chen SA
    Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study".
    Circulation. 2019;139:146-147.
    PubMed     Text format    


  28. ALDAAS OM, Nishimura M, Hsu JC
    Letter by Aldaas et al Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study".
    Circulation. 2019;139:144-145.
    PubMed     Text format    


    December 2018
  29. FRIEDMAN DJ, Al-Khatib SM
    Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2972-2973.
    PubMed     Text format    


  30. BROUWER TF, Burke MC, Knops RE
    Letter by Brouwer et al Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2970-2971.
    PubMed     Text format    



  31. Correction to: Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of
    Circulation. 2018;138:e783.
    PubMed     Text format    


  32. AMBROSY AP, Parzynski CS, Friedman DJ, Fudim M, et al
    Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
    Circulation. 2018;138:2787-2797.
    PubMed     Text format     Abstract available


  33. VAN REIN N, Heide-Jorgensen U, Lijfering WM, Dekkers OM, et al
    Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results from a Nationwide Danish Cohort Study.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.036248.
    PubMed     Text format     Abstract available


  34. PANCHAL AR, Berg KM, Kudenchuk PJ, Del Rios M, et al
    2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation an
    Circulation. 2018;138:e740-e749.
    PubMed     Text format     Abstract available


    November 2018
  35. BASSAND JP, Virdone S, Goldhaber SZ, Camm AJ, et al
    Early Risks of Death, Stroke/Systemic Embolism and Major Bleeding in Patients with Newly Diagnosed Atrial Fibrillation: Results from the GARFIELD-AF Registry.
    Circulation. 2018 Nov 28. doi: 10.1161/CIRCULATIONAHA.118.035012.
    PubMed     Text format     Abstract available


  36. VAN WAGONER DR, Chung MK
    Inflammation, Inflammasome Activation, and Atrial Fibrillation.
    Circulation. 2018;138:2243-2246.
    PubMed     Text format    


  37. BERG DD, Ruff CT, Jarolim P, Giugliano RP, et al
    Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038312.
    PubMed     Text format     Abstract available


  38. SLOTWINER DJ, Raitt MH, Del-Carpio Munoz F, Mulpuru SK, et al
    Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia
    Circulation. 2018 Nov 6:CIR0000000000000629. doi: 10.1161/CIR.0000000000000629.
    PubMed     Text format    


  39. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay.
    Circulation. 2018 Nov 6:CIR0000000000000628. doi: 10.1161/CIR.0000000000000628.
    PubMed     Text format    


  40. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary.
    Circulation. 2018 Nov 6:CIR0000000000000627. doi: 10.1161/CIR.0000000000000627.
    PubMed     Text format    


    October 2018
  41. DI BIASE L, Natale A, Romero J
    Thrombogenic and Arrhythmogenic Roles of the Left Atrial Appendage in Atrial Fibrillation.
    Circulation. 2018;138:2036-2050.
    PubMed     Text format     Abstract available


  42. YAGISHITA A, Goya M, Hirao K
    Simultaneous Recording of the P Wave During Atrial Fibrillation.
    Circulation. 2018;138:2057-2060.
    PubMed     Text format    


  43. LEI M, Wu L, Terrar DA, Huang CL, et al
    Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Circulation. 2018;138:1879-1896.
    PubMed     Text format     Abstract available



  44. Correction to: Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States.
    Circulation. 2018;138:e425.
    PubMed     Text format    


  45. CHAO TF, Chiang CE, Lin YJ, Chang SL, et al
    Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.
    Circulation. 2018;138:1485-1487.
    PubMed     Text format    


  46. MAHESHWARI A, Norby FL, Roetker NS, Soliman EZ, et al
    Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score: The Atherosclerosis Risk in Communities (ARIC) Study and Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2018 Oct 2. doi: 10.1161/CIRCULATIONAHA.118.035411.
    PubMed     Text format     Abstract available


    September 2018

  47. Correction to: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Cl
    Circulation. 2018;138:e415-e418.
    PubMed     Text format    



  48. Correction to: Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Forc
    Circulation. 2018;138:e421.
    PubMed     Text format    



  49. Correction to: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Gui
    Circulation. 2018;138:e419-e420.
    PubMed     Text format    


  50. LEMESLE G
    Aspirin on Top of Anticoagulation in Patients with Concomitant Stable Coronary Artery Disease and Atrial Fibrillation: No Clear Answer Yet.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037440.
    PubMed     Text format    


  51. MATSUMURA-NAKANO Y, Shizuta S, Komasa A, Morimoto T, et al
    An Open-Label Randomized Trial Comparing Oral Anticoagulation with and without Single Antiplatelet Therapy in Patients with Atrial Fibrillation and Stable Coronary Artery Disease Beyond One Year after Coronary Stent Implantation: The OAC-ALONE Study.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.036768.
    PubMed     Text format     Abstract available


  52. DE VEER AJWM, Bennaghmouch N, Mahmoodi BK, Ten Berg JM, et al
    Response by de Veer et al to Letter Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Tria
    Circulation. 2018;138:1279.
    PubMed     Text format    


  53. TONG S, Zhang L, Joseph J
    Letter by Tong et al Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials".
    Circulation. 2018;138:1277-1278.
    PubMed     Text format    


  54. OKADA DR, Smith J, Derakhshan A, Gowani Z, et al
    Ventricular Arrhythmias in Cardiac Sarcoidosis.
    Circulation. 2018;138:1253-1264.
    PubMed     Text format     Abstract available


    August 2018

  55. Correction to: Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2018;138:e123.
    PubMed     Text format    


  56. SARRIAS A, Bayes-Genis A
    Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?
    Circulation. 2018;138:551-553.
    PubMed     Text format    


  57. MARTIN AC, Godier A, Narayanan K, Smadja DM, et al
    Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation.
    Circulation. 2018;138:627-633.
    PubMed     Text format     Abstract available


    July 2018

  58. Correction to: Non-Vitamin K Antagonist Preferred in Patients With Nonvalvular Atrial Fibrillation and Indication for Aspirin Therapy.
    Circulation. 2018;138:e81.
    PubMed     Text format    


  59. ANGIOLILLO DJ, Goodman SG, Bhatt DL, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.
    Circulation. 2018;138:527-536.
    PubMed     Text format     Abstract available


  60. BANAVALIKAR B, Shenthar J, Padmanabhan D
    Unusual Wide Complex Tachycardia During Rhythm Control for Atrial Fibrillation.
    Circulation. 2018;138:537-539.
    PubMed     Text format    


  61. OVERVAD TF, Larsen TB, Nielsen PB
    Response by Overvad et al to Letter Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?"
    Circulation. 2018;138:443-444.
    PubMed     Text format    


  62. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VASc-VA Score Rather Than CHA2DS2-VASc?"
    Circulation. 2018;138:441-442.
    PubMed     Text format    


  63. GOLD MR
    Response by Gold to Letter Regarding Article, "Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?"
    Circulation. 2018;138:124.
    PubMed     Text format    


  64. REIFFEL JA
    Letter by Reiffel Regarding Article, "Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?"
    Circulation. 2018;138:122-123.
    PubMed     Text format    


    June 2018
  65. SIONTIS KC, Zhang X, Eckard A, Bhave N, et al
    Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States.
    Circulation. 2018 Jun 28. pii: CIRCULATIONAHA.118.035418.
    PubMed     Text format     Abstract available


  66. SHARMA A, Hijazi Z, Andersson U, Al-Khatib SM, et al
    The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Circulation. 2018 Jun 5. pii: CIRCULATIONAHA.118.034125.
    PubMed     Text format     Abstract available



  67. Correction to: Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Circulation. 2018;137:e842.
    PubMed     Text format    


  68. ROWIN EJ, Maron MS, Maron BJ
    Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2541-2542.
    PubMed     Text format    


  69. WANG L, Zhao YT
    Letter by Wang and Zhao Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2540.
    PubMed     Text format    


  70. ZHANG L, Xu XM
    Letter by Zhang and Xu Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2539.
    PubMed     Text format    


    May 2018
  71. PACKER M, Kowey PR
    Building Castles in the Sky: Catheter Ablation in Patients With Atrial Fibrillation and Chronic Heart Failure.
    Circulation. 2018 May 30. pii: CIRCULATIONAHA.118.034583.
    PubMed     Text format     Abstract available


  72. YAO C, Veleva T, Scott L Jr, Cao S, et al
    Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
    Circulation. 2018 May 25. pii: CIRCULATIONAHA.118.035202.
    PubMed     Text format     Abstract available


  73. NAZHA B, Pandya B, Cohen J, Zhang M, et al
    Periprocedural Outcomes of Direct Oral Anticoagulants vs. Warfarin in Non-Valvular Atrial Fibrillation: A Meta-analysis of Phase III Trials.
    Circulation. 2018 May 24. pii: CIRCULATIONAHA.117.031457.
    PubMed     Text format     Abstract available


  74. ENRIQUEZ A, Saenz LC, Rosso R, Silvestry FE, et al
    Use of Intracardiac Echocardiography in Interventional Cardiology: Working With the Anatomy Rather Than Fighting It.
    Circulation. 2018;137:2278-2294.
    PubMed     Text format     Abstract available


  75. HALCOX JPJ, Wareham K
    Response by Halcox and Wareham to Letter Regarding Article, "Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study".
    Circulation. 2018;137:2193-2194.
    PubMed     Text format    


  76. KOSHY AN, Sajeev JK, Teh AW
    Letter by Koshy et al Regarding Article, "Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study".
    Circulation. 2018;137:2191-2192.
    PubMed     Text format    


  77. ELMING MB, Signorovitch J, Kober L, Thune JJ, et al
    Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2190.
    PubMed     Text format    


  78. ADABAG S, Wininger M, Singh SN
    Letter by Adabag et al Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2188-2189.
    PubMed     Text format    


  79. MAGNUSSEN C, Ojeda FM, Schnabel RB
    Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk
    Circulation. 2018;137:2087-2088.
    PubMed     Text format    


  80. WANG Y
    Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
    Circulation. 2018;137:2085-2086.
    PubMed     Text format    


  81. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessmen
    Circulation. 2018;137:2083-2084.
    PubMed     Text format    


  82. KANAGASUNDRAM AN, John RM, Stevenson WG
    Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Circulation. 2018;137:1885-1887.
    PubMed     Text format    


    April 2018
  83. O'BRIEN EC, Holmes DN, Thomas LE, Fonarow GC, et al
    Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation.
    Circulation. 2018 Apr 20. pii: CIRCULATIONAHA.117.031354.
    PubMed     Text format     Abstract available


  84. CHEN LY, Chung MK, Allen LA, Ezekowitz M, et al
    Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 16. pii: CIR.0000000000000568.
    PubMed     Text format     Abstract available


  85. TIKKANEN E, Gustafsson S, Ingelsson E
    Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study.
    Circulation. 2018 Apr 9. pii: CIRCULATIONAHA.117.032432.
    PubMed     Text format     Abstract available


  86. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Response by Lau et al to Letters Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1534-1535.
    PubMed     Text format    


  87. BORGHI C, Cicero AFG
    Letter by Borghi and Cicero Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1532-1533.
    PubMed     Text format    


  88. ZEI PC
    Letter by Zei Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1530-1531.
    PubMed     Text format    


  89. SPARTALIS M, Tzatzaki E, Spartalis E
    Letter by Spartalis et al Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1528-1529.
    PubMed     Text format    


    March 2018
  90. ZAUNER CA, Holshouser JW, Littmann L
    Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease.
    Circulation. 2018;137:1287-1289.
    PubMed     Text format    


  91. JAMES S
    Non-Vitamin K Antagonist Preferred in Patients With Nonvalvular Atrial Fibrillation and Indication for Aspirin Therapy.
    Circulation. 2018;137:1130-1131.
    PubMed     Text format    


  92. JAAKKOLA J, Jaakkola S, Lahdenoja O, Hurnanen T, et al
    Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography: The MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation).
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.117.032804.
    PubMed     Text format     Abstract available


    February 2018
  93. CHAO TF, Liu CJ, Lin YJ, Chang SL, et al
    Oral Anticoagulation in Very Elderly Patients with Atrial Fibrillation - A Nationwide Cohort Study.
    Circulation. 2018 Feb 28. pii: CIRCULATIONAHA.117.031658.
    PubMed     Text format     Abstract available


  94. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
    Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
    Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
    PubMed     Text format     Abstract available


  95. NIELSEN PB, Skjoth F, Overvad TF, Larsen TB, et al
    Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
    Circulation. 2018;137:832-840.
    PubMed     Text format     Abstract available


  96. BALLESTEROS G, Menendez D, Ramos P, Garcia-Bolao I, et al
    Broad... Narrow... Broad QRS Tachycardia.
    Circulation. 2018;137:743-746.
    PubMed     Text format    


  97. BEACH LY, Goldschlager N, Moss JD, Scheinman MM, et al
    Response by Beach et al to Letter Regarding Article, "Idiopathic Ventricular Fibrillation in a 29-Year-Old Man".
    Circulation. 2018;137:645.
    PubMed     Text format    


  98. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Idiopathic Ventricular Fibrillation in a 29-Year-Old Man".
    Circulation. 2018;137:643-644.
    PubMed     Text format    


  99. GIUDICESSI JR, Roden DM, Wilde AAM, Ackerman MJ, et al
    Classification and Reporting of Potentially Proarrhythmic Common Genetic Variation in Long QT Syndrome Genetic Testing.
    Circulation. 2018;137:619-630.
    PubMed     Text format     Abstract available


    January 2018
  100. REDDY YNV, Obokata M, Gersh BJ, Borlaug BA, et al
    High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.
    Circulation. 2018;137:534-535.
    PubMed     Text format    


  101. FARRE J, Wellens HJ
    Unique ECG During Sinus Rhythm in a Patient With a Postmyocardial Infarction-Sustained Ventricular Tachycardia.
    Circulation. 2018;137:527-530.
    PubMed     Text format    


  102. AL-KHATIB SM, Gillis AM, Curtis AB
    Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now?
    Circulation. 2018;137:317-319.
    PubMed     Text format    


  103. GOLD MR
    Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?
    Circulation. 2018;137:217-218.
    PubMed     Text format    


  104. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation".
    Circulation. 2018;137:315-316.
    PubMed     Text format    


  105. MIRANDA-ARBOLEDA AF, Correa R, Saenz G, Agudelo JF, et al
    Young Male With Incessantly Wide Complex Tachycardia: What Is the Substrate of the Arrhythmia?
    Circulation. 2018;137:300-302.
    PubMed     Text format    


  106. BARANCHUK A, Torner P, de Luna AB
    Bayes Syndrome: What Is It?
    Circulation. 2018;137:200-202.
    PubMed     Text format    


  107. FISHER M, Hill JA
    Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Circulation. 2018;137:103-105.
    PubMed     Text format    


  108. VOIGT A, Saba S
    The Truth Is in the Details: The Case for Not Missing the Trees for the Forest.
    Circulation. 2018;137:34-37.
    PubMed     Text format    


  109. LEE JZ, Ling J, Diehl NN, Hodge DO, et al
    Mortality and Cerebrovascular Events After Heart Rhythm Disorder Management Procedures.
    Circulation. 2018;137:24-33.
    PubMed     Text format     Abstract available


    December 2017
  110. MAHIDA S, Sacher F, Dubois R, Sermesant M, et al
    Cardiac Imaging in Patients With Ventricular Tachycardia.
    Circulation. 2017;136:2491-2507.
    PubMed     Text format     Abstract available


  111. SPIRITO P
    Atrial Fibrillation in Hypertrophic Cardiomyopathy: New Light on an Old Problem.
    Circulation. 2017;136:2437-2439.
    PubMed     Text format    


  112. BUTTS B, Goeddel LA, George DJ, Steele C, et al
    Increased Inflammation in Pericardial Fluid Persists 48 Hours After Cardiac Surgery.
    Circulation. 2017;136:2284-2286.
    PubMed     Text format    


    November 2017
  113. SELMER C, Faber J
    Mild Thyroid Dysfunction: A Potential Target in Prevention of Atrial Fibrillation?
    Circulation. 2017;136:2117-2118.
    PubMed     Text format    


  114. CALKINS H, Corrado D, Marcus F
    Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2017;136:2068-2082.
    PubMed     Text format     Abstract available


  115. WENG LC, Preis SR, Hulme OL, Larson MG, et al
    Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Circulation. 2017 Nov 12. pii: CIRCULATIONAHA.117.031431.
    PubMed     Text format     Abstract available


  116. AL-KHATIB SM, Pokorney SD
    Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?
    Circulation. 2017;136:1781-1783.
    PubMed     Text format    


  117. SANDAU KE, Funk M, Auerbach A, Barsness GW, et al
    Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association.
    Circulation. 2017;136:e273-e344.
    PubMed     Text format     Abstract available


  118. BENNAGHMOUCH N, de Veer AJWM, Bode K, Mahmoodi BK, et al
    The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028513.
    PubMed     Text format     Abstract available


  119. MANDALENAKIS Z, Rosengren A, Lappas G, Eriksson P, et al
    Atrial Fibrillation Burden in Young Patients with Congenital Heart Disease.
    Circulation. 2017 Nov 1. pii: CIRCULATIONAHA.117.029590.
    PubMed     Text format     Abstract available


    October 2017
  120. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice
    Circulation. 2017 Oct 30. pii: CIR.0000000000000548.
    PubMed     Text format    


  121. KUSUMOTO FM, Bailey KR, Chaouki AS, Deshmukh AJ, et al
    Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    Circulation. 2017 Oct 30. pii: CIR.0000000000000550.
    PubMed     Text format    


  122. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the
    Circulation. 2017 Oct 30. pii: CIR.0000000000000549.
    PubMed     Text format    


  123. BAUMGARTNER C, da Costa BR, Collet TH, Feller M, et al
    Thyroid Function Within the Normal Range, Subclinical Hypothyroidism and the Risk of Atrial Fibrillation.
    Circulation. 2017 Oct 23. pii: CIRCULATIONAHA.117.028753.
    PubMed     Text format     Abstract available


  124. BAREFIELD DY, Puckelwartz MJ, Kim EY, Wilsbacher LD, et al
    Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy.
    Circulation. 2017;136:1477-1491.
    PubMed     Text format     Abstract available


  125. MAGNUSSEN C, Niiranen TJ, Ojeda F, Gianfagna F, et al
    Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
    Circulation. 2017 Oct 16. pii: CIRCULATIONAHA.117.028981.
    PubMed     Text format     Abstract available


  126. CHO JH, Zhang R, Kilfoil PJ, Gallet R, et al
    Delayed Repolarization Underlies Ventricular Arrhythmias in Rats with Heart Failure and Preserved Ejection Fraction.
    Circulation. 2017 Oct 3. pii: CIRCULATIONAHA.117.028202.
    PubMed     Text format     Abstract available


  127. WIJESURENDRA RS, Casadei B
    Seek and Ye Shall Find Subclinical Atrial Fibrillation in High-Risk Elderly Patients.
    Circulation. 2017;136:1284-1287.
    PubMed     Text format    


    September 2017
  128. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    PubMed     Text format     Abstract available


  129. PARKASH R, Sapp JL, Healey JS, Tang ASL, et al
    Response by Parkash et al to Letters Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggres
    Circulation. 2017;136:1271-1272.
    PubMed     Text format    


  130. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive B
    Circulation. 2017;136:1269-1270.
    PubMed     Text format    


  131. KOSIUK J, Linz D, Hindricks G
    Letter by Kosiuk et al Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pre
    Circulation. 2017;136:1267-1268.
    PubMed     Text format    


  132. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label Clinical Trial (SMAC-AF [Substrate Modification with Aggressive Blood Pressur
    Circulation. 2017;136:1265-1266.
    PubMed     Text format    


  133. KAPUR S, Barbhaiya C, Deneke T, Michaud GF, et al
    Esophageal Injury and Atrioesophageal Fistula Caused by Ablation for Atrial Fibrillation.
    Circulation. 2017;136:1247-1255.
    PubMed     Text format     Abstract available


  134. ROWIN EJ, Hausvater A, Link MS, Abt P, et al
    Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
    PubMed     Text format     Abstract available


  135. KUDENCHUK PJ, Leroux BG, Daya M, Rea T, et al
    Antiarrhythmic Drugs for Non-Shockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The Amiodarone, Lidocaine or Placebo Study (ALPS).
    Circulation. 2017 Sep 13. pii: CIRCULATIONAHA.117.028624.
    PubMed     Text format     Abstract available


  136. AUFFRET V, Puri R, Urena M, Chamandi C, et al
    Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.
    Circulation. 2017;136:1049-1069.
    PubMed     Text format     Abstract available


  137. ELMING MB, Nielsen JC, Haarbo J, Videbaek L, et al
    Age and Outcomes of Primary Prevention Implantable Cardioverter Defibrillators in Patients with Non-Ischemic Systolic Heart Failure.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.028829.
    PubMed     Text format     Abstract available


    August 2017
  138. WALDO AL, Camm AJ
    Atrial Fibrillation: Atrial High-Rate Events (AHRES): Look and You Will Find-Then What?
    Circulation. 2017 Aug 28. pii: CIRCULATIONAHA.117.030705.
    PubMed     Text format     Abstract available


  139. HALCOX JPJ, Wareham K, Cardew A, Gilmore M, et al
    Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.
    Circulation. 2017 Aug 28. pii: CIRCULATIONAHA.117.030583.
    PubMed     Text format     Abstract available


  140. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation. 2017;136:583-596.
    PubMed     Text format     Abstract available


  141. HEALEY JS, Alings M, Ha AC, Leong-Sit P, et al
    Subclinical Atrial Fibrillation in Older Patients.
    Circulation. 2017 Aug 4. pii: CIRCULATIONAHA.117.028845.
    PubMed     Text format     Abstract available


  142. KALMAN JM, Sanders P, Rosso R, Calkins H, et al
    Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
    Circulation. 2017;136:490-499.
    PubMed     Text format     Abstract available


    July 2017
  143. CHATTERJEE NA, Chasman DI, Albert CM
    Response by Chatterjee et al to Letter Regarding Article, "Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates From Mendelian Randomization".
    Circulation. 2017;136:434-435.
    PubMed     Text format    


  144. KON KOH K
    Letter by Koh Regarding Article, "Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates from Mendelian Randomization".
    Circulation. 2017;136:432-433.
    PubMed     Text format    


  145. GIBSON CM, Fox K
    Response by Gibson and Fox to Letter Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonis
    Circulation. 2017;136:117.
    PubMed     Text format    


  146. CERIT L
    Letter by Cerit Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy"
    Circulation. 2017;136:115-116.
    PubMed     Text format    


  147. BEACH LY, Goldschlager N, Moss JD, Scheinman MM, et al
    Idiopathic Ventricular Fibrillation in a 29-Year-Old Man.
    Circulation. 2017;136:112-114.
    PubMed     Text format    


    June 2017
  148. GOLWALA H, Bajaj NS, Arora G, Arora P, et al
    Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1200-e1202.
    PubMed     Text format    


  149. NERY PB, Lewis KB, Birnie DH
    Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1198-e1199.
    PubMed     Text format    


  150. BARAKAT AF, Saad M, Elgendy IY
    Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1196-e1197.
    PubMed     Text format    


  151. LAMPERT R, Olshansky B, Heidbuchel H, Lawless C, et al
    Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry.
    Circulation. 2017;135:2310-2312.
    PubMed     Text format    


  152. COYLEWRIGHT M, Holmes DR Jr
    Caution Regarding Government-Mandated Shared Decision Making for Patients With Atrial Fibrillation.
    Circulation. 2017;135:2211-2213.
    PubMed     Text format    


  153. YAMAGATA K, Horie M, Aiba T, Ogawa S, et al
    Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry.
    Circulation. 2017;135:2255-2270.
    PubMed     Text format     Abstract available


    May 2017
  154. FREEDMAN B, Camm J, Calkins H, Healey JS, et al
    Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.
    Circulation. 2017;135:1851-1867.
    PubMed     Text format     Abstract available


  155. LAU DH, Hendriks J, Kalman JM, Sanders P, et al
    Blood Pressure Control in Atrial Fibrillation: One of Many Critical Components in Risk Factor Modification.
    Circulation. 2017;135:1799-1801.
    PubMed     Text format    



  156. Correction to: Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes.
    Circulation. 2017;135:e1016.
    PubMed     Text format    


  157. FENDER EA, Widmer RJ, Holmes DR Jr, Packer DL, et al
    Response by Fender et al to Letter Regarding Article, "Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes".
    Circulation. 2017;135:e1014-e1015.
    PubMed     Text format    


  158. JAZAYERI MA, Reddy YM, Lakkireddy DR
    Letter by Jazayeri et al Regarding Article, "Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes".
    Circulation. 2017;135:e1012-e1013.
    PubMed     Text format    


    April 2017
  159. FLYER JN, Zuckerman WA, Richmond ME, Anderson BR, et al
    Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplant.
    Circulation. 2017 Apr 27. pii: CIRCULATIONAHA.117.028087.
    PubMed     Text format     Abstract available


  160. VERMA A, Kalman JM, Callans DJ
    Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
    Circulation. 2017;135:1547-1563.
    PubMed     Text format     Abstract available


  161. TJONG FV, Reddy VY
    Permanent Leadless Cardiac Pacemaker Therapy: A Comprehensive Review.
    Circulation. 2017;135:1458-1470.
    PubMed     Text format     Abstract available


  162. STRAUSS DG, Vicente J, Johannesen L, Blinova K, et al
    Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Circulation. 2017;135:1300-1310.
    PubMed     Text format     Abstract available


    March 2017
  163. SCHEINMAN MA, Rutherford JD
    The Development of Cardiac Arrhythmia Ablation: A Conversation With Melvin A. Scheinman, MD.
    Circulation. 2017;135:1191-1193.
    PubMed     Text format     Abstract available



  164. Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2017;135:e789.
    PubMed     Text format    


  165. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Text format     Abstract available


  166. RAVAL AN, Cigarroa JE, Chung MK, Diaz-Sandoval LJ, et al
    Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.
    Circulation. 2017;135:e604-e633.
    PubMed     Text format     Abstract available


    February 2017
  167. WHITMAN IR, Gladstone RA, Badhwar N, Hsia HH, et al
    Brain Emboli After Left Ventricular Endocardial Ablation.
    Circulation. 2017;135:867-877.
    PubMed     Text format     Abstract available


  168. CARNICELLI AP, De Caterina R, Halperin JL, Renda G, et al
    Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.026714.
    PubMed     Text format     Abstract available


  169. CHOWDHURY SK, Liu W, Zi M, Li Y, et al
    Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention.
    Circulation. 2017;135:683-699.
    PubMed     Text format     Abstract available


  170. SIONTIS KC, Yao X, Gersh BJ, Noseworthy PA, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.
    Circulation. 2017;135:714-716.
    PubMed     Text format    


  171. RAO MP, Al-Khatib SM, Pokorney S, She L, et al
    Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
    PubMed     Text format     Abstract available


    January 2017
  172. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    PubMed     Text format     Abstract available


    December 2016
  173. WIBERG S, Hassager C, Schmidt H, Thomsen JH, et al
    Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial.
    Circulation. 2016;134:2115-2124.
    PubMed     Text format     Abstract available


  174. GOTO Y, Funada A, Goto Y
    Duration of Prehospital Cardiopulmonary Resuscitation and Favorable Neurological Outcomes for Pediatric Out-of-Hospital Cardiac Arrests: A Nationwide, Population-Based Cohort Study.
    Circulation. 2016;134:2046-2059.
    PubMed     Text format     Abstract available


    November 2016
  175. AL-KHATIB SM, Friedman P, Ellenbogen KA
    Defibrillators: Selecting the Right Device for the Right Patient.
    Circulation. 2016;134:1390-1404.
    PubMed     Text format     Abstract available


  176. ALVAREZ-GARCIA J, Vives-Borras M, Gomis P, Ordonez-Llanos J, et al
    Response by Alvarez-Garcia et al to Letters Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e401-e402.
    PubMed     Text format    


  177. BARANCHUK A
    Letter by Baranchuk Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e399-e400.
    PubMed     Text format    


  178. NG FS, Efimov IR
    Letter by Ng and Efimov Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e397-e398.
    PubMed     Text format    


    October 2016
  179. HAMPTON T
    Energy Drinks Pose Worrisome Risks to Adolescents' Cardiovascular Health.
    Circulation. 2016;134:1052-1053.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: